Japanese multinational IT and electronics company NEC recently announced the development of its WISE VISION Endoscopy, an AI diagnosis-support medical device software for colonoscopies, which was just released in Japan and is expected to soon be available in Europe. The software connects with existing endoscopy equipment as part of using AI to automatically mark potential lesions from images taken during endoscopic procedures.
WHY IT MATTERS
According to NEC’s official release, colorectal cancer is the most common cancer in Japan and the second most common in Europe. Colorectal cancer originates from precancerous lesions (colorectal neoplastic polyps) and it is possible to suppress the progression to cancer by detecting and removing lesions at the polyp stage during endoscopy procedures.
However, polyps need to be found with the eye of an endoscopist, and are often difficult to detect because of their size and shape, causing approximately 24% (according to a journal article by Gastroenterology) to be missed, thereby delaying detection.
NEC has been working with the National Cancer Center Japan since 2016 to contribute to resolving this issue. NEC has now developed software that can automatically mark potential